Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Post-operative Analgesia in Foot and Ankle Arthrodesis
NCT02586077Phase 4
Key facts
- Status
- Completed
- Start
- Feb 2014
- Primary completion
- Jun 2016
- Countries
- 1
- Sponsor
- OrthoCarolina Research Institute
- Modality
- Small Molecules
- Drugs
- bupivacaine
- Conditions
- postoperative pain
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain, sponsored by OrthoCarolina Research Institute. Primary endpoint: Amount of Narcotic Use. Started Feb 2014; status: completed.
02
Design
- Study design
- Non-randomizedOpen-labelSingle group
03
Endpoints
Primary
Amount of Narcotic Use
Secondary
Visual Analog Scale of Pain
Beyond the preview
Go deeper on NCT02586077.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586077.